Picture
SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare
Free Samples
Drug Delivery Devices

PUBLISHER: Fairfield Market Research | PRODUCT CODE: 1394088

Cover Image

PUBLISHER: Fairfield Market Research | PRODUCT CODE: 1394088

Pneumatic Nebulizers Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2031 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa)

PUBLISHED:
PAGES: 250 Pages
DELIVERY TIME: 2-5 business days
REQUEST FREE SAMPLE
REQUEST CUSTOMIZATION
SELECT AN OPTION
Unprintable PDF & Excel (Single User License)
USD 4995
Unprintable PDF & Excel (Multi User License upto 5 users)
USD 8495
Printable PDF & Excel (Enterprise License above 5 users)
USD 10600

Add to Cart

Description

Table of Contents

The global Pneumatic Nebulizers market, valued at approximately US$800 million in 2024, is set to experience significant growth in the coming decade. Market is expected to reach a valuation of nearly US$1400 million by the end of 2031.

Rising Respiratory Disorders Drive Market Growth

One of the primary factors fueling the growth of the Global Pneumatic Nebulizers Market is the substantial increase in respiratory disorders worldwide. Conditions such as asthma, cystic fibrosis, and chronic obstructive pulmonary disease (COPD) have seen a significant rise in prevalence over the years. Data from a recent report reveals that as of 2019, approximately 262 million people were suffering from asthma, a number expected to further expand during the forecast period. This increase in patients is poised to drive the demand for Pneumatic Nebulizers, as they prove to be crucial in managing these respiratory conditions effectively.

Cost-efficiency and Ease of Operability Boost Adoption

The market's growth is further propelled by the cost-efficiency and user-friendly nature of Pneumatic Nebulizers compared to other nebulizers available in the market. Additionally, third-party entities, such as insurance providers, are inclined toward the use of pneumatic nebulizers due to their cost-effectiveness while still delivering high-quality medical services to patients.

North America Leads with Over 30% Market Share

In the Global Pneumatic Nebulizers Market, North America has emerged as a dominant player, holding a market share of more than 30%. The region's increasing population affected by respiratory disorders, including Chronic Obstructive Pulmonary Disease (COPD) and asthma, is expected to sustain this leading position in the years to come.

Key Players Driving Market Innovation

Prominent companies such as Koninklijke Philips N.V., Omron Corporation, General Electric, and Medline Industries Inc., among others, are at the forefront of shaping the competitive landscape of the Pneumatic Nebulizers market. These industry leaders are adopting strategies such as mergers, acquisitions, partnerships, and new product launches to expand their product portfolio and meet the growing market demand.

As the Pneumatic Nebulizers market continues to evolve, consumers can anticipate advancements in respiratory care, driven by innovation and a commitment to improving the lives of individuals suffering from respiratory disorders.

Key Companies Mentioned:

  • Koninklijke Philips N.V.
  • Omron Corporation
  • General Electric
  • Medline Industries Inc.
  • BD (Becton, Dickinson & Company)
  • Allied Healthcare Products
  • Philips Respironics Inc.
  • Briggs Healthcare
  • Heyer Medical AG
  • Medtronic PLC
  • PARI Pharma GmbH
  • Airssential Health Care
  • Vectura Group Plc.
  • DeVilbiss Healthcare
  • Flexicare Medical Ltd.
  • Clement Clarke International

Key Segments Covered in Market Survey

By Product-type

  • Breath-actuated
  • Vented

By End-use

  • Hospitals & Clinics
  • Home Healthcare

By Region

  • North America
    • The US
    • Canada
  • The Asia Pacific
    • China
    • Japan
    • South Korea
    • India
  • Europe
    • Germany
    • The UK
    • France
    • Russia
    • Italy
  • The Middle East and Africa (MEA)
    • South Africa
    • Saudi Arabia
    • UAE
    • Nigeria
    • Egypt
  • Latin America
    • Mexico
    • Brazil
    • Argentina
    • Colombia
Show more

Table of Contents

1. Executive Summary

  • 1.1. Global Pneumatic Nebulizers Market Snapshot
  • 1.2. Future Projections
  • 1.3. Key Market Trends
  • 1.4. Regional Snapshot, by Value, 2023
  • 1.5. Analyst Recommendations

2. Market Overview

  • 2.1. Market Definitions and Segmentations
  • 2.2. Market Dynamics
    • 2.2.1. Drivers
    • 2.2.2. Restraints
    • 2.2.3. Market Opportunities
  • 2.3. Value Chain Analysis
  • 2.4. Porter's Five Forces Analysis
  • 2.5. COVID-19 Impact Analysis
    • 2.5.1. Supply
    • 2.5.2. Demand
  • 2.6. Impact of Ukraine-Russia Conflict
  • 2.7. Economic Overview
    • 2.7.1. World Economic Projections
  • 2.8. PESTLE Analysis

3. Global Pneumatic Nebulizers Market Outlook, 2018 - 2031

  • 3.1. Global Pneumatic Nebulizers Market Outlook, By Product Type, Value (US$ Mn), 2018 - 2031
    • 3.1.1. Key Highlights
      • 3.1.1.1. Breath-actuated
      • 3.1.1.2. Vented
  • 3.2. Global Pneumatic Nebulizers Market Outlook, By End-use, Value (US$ Mn), 2018 - 2031
    • 3.2.1. Key Highlights
      • 3.2.1.1. Hospitals & Clinics
      • 3.2.1.2. Home Healthcare
  • 3.3. Global Pneumatic Nebulizers Market Outlook, by Region, Value (US$ Mn), 2018 - 2031
    • 3.3.1. Key Highlights
      • 3.3.1.1. North America
      • 3.3.1.2. Europe
      • 3.3.1.3. Asia Pacific
      • 3.3.1.4. Latin America
      • 3.3.1.5. Middle East & Africa

4. North America Pneumatic Nebulizers Market Outlook, 2018 - 2031

  • 4.1. North America Pneumatic Nebulizers Market Outlook, By Product Type, Value (US$ Mn), 2018 - 2031
    • 4.1.1. Key Highlights
      • 4.1.1.1. Breath-actuated
      • 4.1.1.2. Vented
  • 4.2. North America Pneumatic Nebulizers Market Outlook, By End-use, Value (US$ Mn), 2018 - 2031
    • 4.2.1. Key Highlights
      • 4.2.1.1. Hospitals & Clinics
      • 4.2.1.2. Home Healthcare
    • 4.2.2. BPS Analysis/Market Attractiveness Analysis
  • 4.3. North America Pneumatic Nebulizers Market Outlook, by Country, Value (US$ Mn), 2018 - 2031
    • 4.3.1. Key Highlights
      • 4.3.1.1. U.S. Pneumatic Nebulizers Market By Product Type, Value (US$ Mn), 2018 - 2031
      • 4.3.1.2. U.S. Pneumatic Nebulizers Market By End-use, Value (US$ Mn), 2018 - 2031
      • 4.3.1.3. Canada Pneumatic Nebulizers Market By Product Type, Value (US$ Mn), 2018 - 2031
      • 4.3.1.4. Canada Pneumatic Nebulizers Market By End-use, Value (US$ Mn), 2018 - 2031
    • 4.3.2. BPS Analysis/Market Attractiveness Analysis

5. Europe Pneumatic Nebulizers Market Outlook, 2018 - 2031

  • 5.1. Europe Pneumatic Nebulizers Market Outlook, By Product Type, Value (US$ Mn), 2018 - 2031
    • 5.1.1. Key Highlights
      • 5.1.1.1. Breath-actuated
      • 5.1.1.2. Vented
  • 5.2. Europe Pneumatic Nebulizers Market Outlook, By End-use, Value (US$ Mn), 2018 - 2031
    • 5.2.1. Key Highlights
      • 5.2.1.1. Hospitals & Clinics
      • 5.2.1.2. Home Healthcare
    • 5.2.2. BPS Analysis/Market Attractiveness Analysis
  • 5.3. Europe Pneumatic Nebulizers Market Outlook, by Country, Value (US$ Mn), 2018 - 2031
    • 5.3.1. Key Highlights
      • 5.3.1.1. Germany Pneumatic Nebulizers Market By Product Type, Value (US$ Mn), 2018 - 2031
      • 5.3.1.2. Germany Pneumatic Nebulizers Market By End-use, Value (US$ Mn), 2018 - 2031
      • 5.3.1.3. U.K. Pneumatic Nebulizers Market By Product Type, Value (US$ Mn), 2018 - 2031
      • 5.3.1.4. U.K. Pneumatic Nebulizers Market By End-use, Value (US$ Mn), 2018 - 2031
      • 5.3.1.5. France Pneumatic Nebulizers Market By Product Type, Value (US$ Mn), 2018 - 2031
      • 5.3.1.6. France Pneumatic Nebulizers Market By End-use, Value (US$ Mn), 2018 - 2031
      • 5.3.1.7. Italy Pneumatic Nebulizers Market By Product Type, Value (US$ Mn), 2018 - 2031
      • 5.3.1.8. Italy Pneumatic Nebulizers Market By End-use, Value (US$ Mn), 2018 - 2031
      • 5.3.1.9. Turkey Pneumatic Nebulizers Market By Product Type, Value (US$ Mn), 2018 - 2031
      • 5.3.1.10. Turkey Pneumatic Nebulizers Market By End-use, Value (US$ Mn), 2018 - 2031
      • 5.3.1.11. Russia Pneumatic Nebulizers Market By Product Type, Value (US$ Mn), 2018 - 2031
      • 5.3.1.12. Russia Pneumatic Nebulizers Market By End-use, Value (US$ Mn), 2018 - 2031
      • 5.3.1.13. Rest of Europe Pneumatic Nebulizers Market By Product Type, Value (US$ Mn), 2018 - 2031
      • 5.3.1.14. Rest of Europe Pneumatic Nebulizers Market By End-use, Value (US$ Mn), 2018 - 2031
    • 5.3.2. BPS Analysis/Market Attractiveness Analysis

6. Asia Pacific Pneumatic Nebulizers Market Outlook, 2018 - 2031

  • 6.1. Asia Pacific Pneumatic Nebulizers Market Outlook, By Product Type, Value (US$ Mn), 2018 - 2031
    • 6.1.1. Key Highlights
      • 6.1.1.1. Breath-actuated
      • 6.1.1.2. Vented
  • 6.2. Asia Pacific Pneumatic Nebulizers Market Outlook, By End-use, Value (US$ Mn), 2018 - 2031
    • 6.2.1. Key Highlights
      • 6.2.1.1. Hospitals & Clinics
      • 6.2.1.2. Home Healthcare
    • 6.2.2. Others BPS Analysis/Market Attractiveness Analysis
  • 6.3. Asia Pacific Pneumatic Nebulizers Market Outlook, by Country, Value (US$ Mn), 2018 - 2031
    • 6.3.1. Key Highlights
      • 6.3.1.1. China Pneumatic Nebulizers Market By Product Type, Value (US$ Mn), 2018 - 2031
      • 6.3.1.2. China Pneumatic Nebulizers Market By End-use, Value (US$ Mn), 2018 - 2031
      • 6.3.1.3. Japan Pneumatic Nebulizers Market By Product Type, Value (US$ Mn), 2018 - 2031
      • 6.3.1.4. Japan Pneumatic Nebulizers Market By End-use, Value (US$ Mn), 2018 - 2031
      • 6.3.1.5. South Korea Pneumatic Nebulizers Market By Product Type, Value (US$ Mn), 2018 - 2031
      • 6.3.1.6. South Korea Pneumatic Nebulizers Market By End-use, Value (US$ Mn), 2018 - 2031
      • 6.3.1.7. India Pneumatic Nebulizers Market By Product Type, Value (US$ Mn), 2018 - 2031
      • 6.3.1.8. India Pneumatic Nebulizers Market By End-use, Value (US$ Mn), 2018 - 2031
      • 6.3.1.9. Southeast Asia Pneumatic Nebulizers Market By Product Type, Value (US$ Mn), 2018 - 2031
      • 6.3.1.10. Southeast Asia Pneumatic Nebulizers Market By End-use, Value (US$ Mn), 2018 - 2031
      • 6.3.1.11. Rest of Asia Pacific Pneumatic Nebulizers Market By Product Type, Value (US$ Mn), 2018 - 2031
      • 6.3.1.12. Rest of Asia Pacific Pneumatic Nebulizers Market By End-use, Value (US$ Mn), 2018 - 2031
    • 6.3.2. BPS Analysis/Market Attractiveness Analysis

7. Latin America Pneumatic Nebulizers Market Outlook, 2018 - 2031

  • 7.1. Latin America Pneumatic Nebulizers Market Outlook, By Product Type, Value (US$ Mn), 2018 - 2031
    • 7.1.1. Key Highlights
      • 7.1.1.1. Breath-actuated
      • 7.1.1.2. Vented
  • 7.2. Latin America Pneumatic Nebulizers Market Outlook, By End-use, Value (US$ Mn), 2018 - 2031
      • 7.2.1.1. Hospitals & Clinics
      • 7.2.1.2. Home Healthcare
    • 7.2.2. BPS Analysis/Market Attractiveness Analysis
  • 7.3. Latin America Pneumatic Nebulizers Market Outlook, by Country, Value (US$ Mn), 2018 - 2031
    • 7.3.1. Key Highlights
      • 7.3.1.1. Brazil Pneumatic Nebulizers Market By Product Type, Value (US$ Mn), 2018 - 2031
      • 7.3.1.2. Brazil Pneumatic Nebulizers Market By End-use, Value (US$ Mn), 2018 - 2031
      • 7.3.1.3. Mexico Pneumatic Nebulizers Market By Product Type, Value (US$ Mn), 2018 - 2031
      • 7.3.1.4. Mexico Pneumatic Nebulizers Market By End-use, Value (US$ Mn), 2018 - 2031
      • 7.3.1.5. Argentina Pneumatic Nebulizers Market By Product Type, Value (US$ Mn), 2018 - 2031
      • 7.3.1.6. Argentina Pneumatic Nebulizers Market By End-use, Value (US$ Mn), 2018 - 2031
      • 7.3.1.7. Rest of Latin America Pneumatic Nebulizers Market By Product Type, Value (US$ Mn), 2018 - 2031
      • 7.3.1.8. Rest of Latin America Pneumatic Nebulizers Market By End-use, Value (US$ Mn), 2018 - 2031
    • 7.3.2. BPS Analysis/Market Attractiveness Analysis

8. Middle East & Africa Pneumatic Nebulizers Market Outlook, 2018 - 2031

  • 8.1. Middle East & Africa Pneumatic Nebulizers Market Outlook, By Product Type, Value (US$ Mn), 2018 - 2031
    • 8.1.1. Key Highlights
      • 8.1.1.1. Breath-actuated
      • 8.1.1.2. Vented
  • 8.2. Middle East & Africa Pneumatic Nebulizers Market Outlook, By End-use, Value (US$ Mn), 2018 - 2031
    • 8.2.1. Key Highlights
      • 8.2.1.1. Hospitals & Clinics
      • 8.2.1.2. Home Healthcare
    • 8.2.2. BPS Analysis/Market Attractiveness Analysis
  • 8.3. Middle East & Africa Pneumatic Nebulizers Market Outlook, by Country, Value (US$ Mn), 2018 - 2031
    • 8.3.1. Key Highlights
      • 8.3.1.1. GCC Pneumatic Nebulizers Market By Product Type, Value (US$ Mn), 2018 - 2031
      • 8.3.1.2. GCC Pneumatic Nebulizers Market By End-use, Value (US$ Mn), 2018 - 2031
      • 8.3.1.3. South Africa Pneumatic Nebulizers Market By Product Type, Value (US$ Mn), 2018 - 2031
      • 8.3.1.4. South Africa Pneumatic Nebulizers Market By End-use, Value (US$ Mn), 2018 - 2031
      • 8.3.1.5. Egypt Pneumatic Nebulizers Market By Product Type, Value (US$ Mn), 2018 - 2031
      • 8.3.1.6. Egypt Pneumatic Nebulizers Market By End-use, Value (US$ Mn), 2018 - 2031
      • 8.3.1.7. Nigeria Pneumatic Nebulizers Market By Product Type, Value (US$ Mn), 2018 - 2031
      • 8.3.1.8. Nigeria Pneumatic Nebulizers Market By End-use, Value (US$ Mn), 2018 - 2031
      • 8.3.1.9. Rest of Middle East & Africa Pneumatic Nebulizers Market By Product Type, Value (US$ Mn), 2018 - 2031
      • 8.3.1.10. Rest of Middle East & Africa Pneumatic Nebulizers Market By End-use, Value (US$ Mn), 2018 - 2031
    • 8.3.2. BPS Analysis/Market Attractiveness Analysis

9. Competitive Landscape

  • 9.1. Manufacturer vs By End-use Heatmap
  • 9.2. Company Market Share Analysis, 2023
  • 9.3. Competitive Dashboard
  • 9.4. Company Profiles
    • 9.4.1. Koninklijke Philips N.V.
      • 9.4.1.1. Company Overview
      • 9.4.1.2. Product Portfolio
      • 9.4.1.3. Financial Overview
      • 9.4.1.4. Business Strategies and Development
    • 9.4.2. General Electric
      • 9.4.2.1. Company Overview
      • 9.4.2.2. Product Portfolio
      • 9.4.2.3. Financial Overview
      • 9.4.2.4. Business Strategies and Development
    • 9.4.3. Medline Industries Inc.
      • 9.4.3.1. Company Overview
      • 9.4.3.2. Product Portfolio
      • 9.4.3.3. Financial Overview
      • 9.4.3.4. Business Strategies and Development
    • 9.4.4. Becton, Dickinson & Company
      • 9.4.4.1. Company Overview
      • 9.4.4.2. Product Portfolio
      • 9.4.4.3. Financial Overview
      • 9.4.4.4. Business Strategies and Development
    • 9.4.5. Allied Healthcare Products
      • 9.4.5.1. Company Overview
      • 9.4.5.2. Product Portfolio
      • 9.4.5.3. Financial Overview
      • 9.4.5.4. Business Strategies and Development
    • 9.4.6. Philips Respironics Inc.
      • 9.4.6.1. Company Overview
      • 9.4.6.2. Product Portfolio
      • 9.4.6.3. Financial Overview
      • 9.4.6.4. Business Strategies and Development
    • 9.4.7. Briggs Healthcare
      • 9.4.7.1. Company Overview
      • 9.4.7.2. Product Portfolio
      • 9.4.7.3. Financial Overview
      • 9.4.7.4. Business Strategies and Development
    • 9.4.8. Heyer Medical AG
      • 9.4.8.1. Company Overview
      • 9.4.8.2. Product Portfolio
      • 9.4.8.3. Financial Overview
      • 9.4.8.4. Business Strategies and Development
    • 9.4.9. Medtronic PLC
      • 9.4.9.1. Company Overview
      • 9.4.9.2. Product Portfolio
      • 9.4.9.3. Financial Overview
      • 9.4.9.4. Business Strategies and Development
    • 9.4.10. PARI Pharma GmbH
      • 9.4.10.1. Company Overview
      • 9.4.10.2. Product Portfolio
      • 9.4.10.3. Financial Overview
      • 9.4.10.4. Business Strategies and Development
    • 9.4.11. Airssential Health Care
      • 9.4.11.1. Company Overview
      • 9.4.11.2. Product Portfolio
      • 9.4.11.3. Financial Overview
      • 9.4.11.4. Business Strategies and Development
    • 9.4.12. Vectura Group Plc
      • 9.4.12.1. Company Overview
      • 9.4.12.2. Product Portfolio
      • 9.4.12.3. Financial Overview
      • 9.4.12.4. Business Strategies and Development
    • 9.4.13. DeVilbiss Healthcare
      • 9.4.13.1. Company Overview
      • 9.4.13.2. Product Portfolio
      • 9.4.13.3. Financial Overview
      • 9.4.13.4. Business Strategies and Development
    • 9.4.14. Flexicare Medical Ltd.
      • 9.4.14.1. Company Overview
      • 9.4.14.2. Product Portfolio
      • 9.4.14.3. Financial Overview
      • 9.4.14.4. Business Strategies and Development
    • 9.4.15. Clement Clarke International
      • 9.4.15.1. Company Overview
      • 9.4.15.2. Product Portfolio
      • 9.4.15.3. Financial Overview
      • 9.4.15.4. Business Strategies and Development

10. Appendix

  • 10.1. Research Methodology
  • 10.2. Report Assumptions
  • 10.3. Acronyms and Abbreviations
Show more
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Contact Us +1-866-353-3335
Hi, how can we help?
Contact us!